Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Ashish Pemawat: Is the 4.5-Hour Thrombolysis Window Becoming Less Relevant?
Ashish Pemawat/LinkedIn
Jun 7, 2026, 19:35

Ashish Pemawat: Is the 4.5-Hour Thrombolysis Window Becoming Less Relevant?

Ashish Pemawat, Associate Director of Institute of Neurosciences, shared on LinkedIn about a recent article by Ahmet Günkan et al, published in Stroke, adding:

”Is the 4.5-hour thrombolysis window becoming less relevant?

A recent meta-analysis published in Stroke (2025) pooled data from 8 randomized controlled trials involving 1,742 patients with acute ischemic stroke treated beyond the conventional 4.5-hour window.

Intravenous thrombolysis increased the odds of:

  • Excellent functional outcome (mRS 0–1): OR 1.43
  • Functional independence (mRS 0–2): OR 1.36

Additional benefits included higher rates of recanalization, reperfusion, and early neurological improvement.

As expected, symptomatic intracerebral hemorrhage was more frequent (OR 4.25), but importantly, there was no statistically significant increase in 90-day mortality.

The key message is clear: patient selection matters more than the clock.

Advanced imaging techniques—particularly perfusion imaging and DWI-FLAIR mismatch—can identify salvageable brain tissue and safely expand access to thrombolysis for selected patients presenting well beyond 4.5 hours or with wake-up stroke.

As stroke care continues to evolve, the paradigm is increasingly shifting from a rigid time-window approach toward a tissue-window approach, allowing more patients to benefit from reperfusion therapy.”

Title: Thrombolysis for Ischemic Stroke Beyond the 4.5-Hour Window: A Meta-Analysis of Randomized Clinical Trials

Authors: Ahmet Günkan, Marcio Yuri Ferreira, Marina Vilardo, Luca Scarcia, Jhon E. Bocanegra-Becerra, Leonardo Januario Campos Cardoso, Luis F. Fabrini Paleare, Gustavo de Oliveira Almeida, Gabriel Semione, Christian Ferreira, Gabriele Ciccio, Adnan Mujanovic, Pascal Jabbour, Yafell Serulle, Thanh N. Nguyen, Jean-Claude Baron

Ashish Pemawat: Is the 4.5-Hour Thrombolysis Window Becoming Less Relevant?

Stay updated on all scientific advances with Hemostasis Today.

Adnan Mujanovic Ahmet Günkan Ashish Pemawat Christian Ferreira Gabriel Semione Gabriele Ciccio Gustavo de Oliveira Almeida Health Hematology Hemostasis Hemostasis News Hemostasis Today Jean-Claude Baron Jhon E. Bocanegra-Becerra Leonardo Januário Campos Cardoso Luca Scarcia Luis F. Fabrini Paleare Marcio Yuri Ferreira Marina Vilardo Medicine Pascal Jabbour reperfusion therapy stroke Thanh N. Nguyen Thrombolysis thrombosis Yafell Serulle
NewsFeed